| 摘要 |
1. Process for the specific determination of pancreatic alpha-amylase in the presence of salivary alpha-amylase in body fluids, especially in serum, plasma, duodenal juice or urine, by reaction with a system for the detection of alpha-amylase in the presence of a monoclonal antibody which reacts with salivary alpha-amylase, characterised in that one uses a monoclonal antibody which specifically inhibits the salivary enzyme but inhibits the pancreatic enzyme by not more than 50%. |
